TY - JOUR AU - Society, B. C. AU - Society, B. H. AU - Diabetes, U. K. PY - 2005 DA - 2005// TI - JBS 2: joint British societies’ guidelines on prevention of cardiovascular disease in clinical practice JO - Heart VL - 91 ID - Society2005 ER - TY - JOUR AU - Studer, M. AU - Briel, M. AU - Leimenstoll, B. AU - Glass, T. R. AU - Bucher, H. C. PY - 2005 DA - 2005// TI - Effect of different antilipidemic agents and diets on mortality: a systematic review JO - Arch Intern Med VL - 165 UR - https://doi.org/10.1001/archinte.165.7.725 DO - 10.1001/archinte.165.7.725 ID - Studer2005 ER - TY - JOUR AU - Shepherd, J. AU - Cobbe, S. M. AU - Ford, I. PY - 1995 DA - 1995// TI - Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland coronary prevention study group JO - N Engl J Med VL - 333 UR - https://doi.org/10.1056/NEJM199511163332001 DO - 10.1056/NEJM199511163332001 ID - Shepherd1995 ER - TY - JOUR AU - Taylor, F. AU - Huffman, M. D. AU - Macedo, A. F. PY - 2013 DA - 2013// TI - Statins for the primary prevention of cardiovascular disease JO - Cochrane Database Syst Rev VL - 1 ID - Taylor2013 ER - TY - JOUR AU - Karlson, B. W. AU - Nicholls, S. J. AU - Lundman, P. PY - 2013 DA - 2013// TI - Achievement of 2011 European low-density lipoprotein cholesterol (LDL-C) goals of either <70 mg/dl or ≥ 50% reduction in high-risk patients: results from VOYAGER JO - Atherosclerosis VL - 228 UR - https://doi.org/10.1016/j.atherosclerosis.2013.02.027 DO - 10.1016/j.atherosclerosis.2013.02.027 ID - Karlson2013 ER - TY - JOUR AU - Yasuda, S. U. AU - Zhang, L. AU - Huang, S. M. PY - 2008 DA - 2008// TI - The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies JO - Clin Pharmacol Ther VL - 84 UR - https://doi.org/10.1038/clpt.2008.141 DO - 10.1038/clpt.2008.141 ID - Yasuda2008 ER - TY - JOUR AU - Wang, P. PY - 2011 DA - 2011// TI - Statin dose in Asians: is pharmacogenetics relevant? JO - Pharmacogenomics VL - 12 UR - https://doi.org/10.2217/pgs.11.98 DO - 10.2217/pgs.11.98 ID - Wang2011 ER - TY - JOUR AU - Cannon, C. P. AU - Braunwald, E. AU - McCabe, C. H. PY - 2004 DA - 2004// TI - Intensive versus moderate lipid lowering with statins after acute coronary syndromes JO - N Engl J Med VL - 350 UR - https://doi.org/10.1056/NEJMoa040583 DO - 10.1056/NEJMoa040583 ID - Cannon2004 ER - TY - JOUR AU - Schwartz, G. G. AU - Olsson, A. G. AU - Ezekowitz, M. D. PY - 2001 DA - 2001// TI - Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial JO - JAMA VL - 285 UR - https://doi.org/10.1001/jama.285.13.1711 DO - 10.1001/jama.285.13.1711 ID - Schwartz2001 ER - TY - JOUR AU - Charland, S. L. AU - Malone, D. C. PY - 2010 DA - 2010// TI - Prediction of cardiovascular event risk reduction from lipid changes associated with high potency dyslipidemia therapy JO - Curr Med Res Opin VL - 26 UR - https://doi.org/10.1185/03007990903484802 DO - 10.1185/03007990903484802 ID - Charland2010 ER - TY - JOUR AU - DerSimonian, R. AU - Laird, N. PY - 1986 DA - 1986// TI - Meta-analysis in clinical trials JO - Control Clin Trials VL - 7 UR - https://doi.org/10.1016/0197-2456(86)90046-2 DO - 10.1016/0197-2456(86)90046-2 ID - DerSimonian1986 ER - TY - JOUR AU - Begg, C. B. AU - Mazumdar, M. PY - 1994 DA - 1994// TI - Operating characteristics of a rank correlation test for publication bias JO - Biometrics VL - 50 UR - https://doi.org/10.2307/2533446 DO - 10.2307/2533446 ID - Begg1994 ER - TY - JOUR AU - Hong, S. J. AU - Jeong, H. S. AU - Ahn, J. C. PY - 2018 DA - 2018// TI - A phase III, multicenter, randomized, double-blind, active comparator clinical trial to Comparethe efficacy and safety of combination therapy with Ezetimibe and Rosuvastatin VersusRosuvastatin Monotherapy in patients with hypercholesterolemia: I-ROSETTE (IldongRosuvastatin & Ezetimibe for hypercholesterolemia) randomized controlled trial JO - Clin Ther VL - 40 UR - https://doi.org/10.1016/j.clinthera.2017.12.018 DO - 10.1016/j.clinthera.2017.12.018 ID - Hong2018 ER - TY - JOUR AU - Ran, D. AU - Nie, H. J. AU - Gao, Y. L. PY - 2017 DA - 2017// TI - A randomized, controlled comparison of different intensive lipid-lowering therapies in Chinese patients withnon-ST-elevationacute coronary syndrome (NSTE-ACS): Ezetimibe and rosuvastatin versus high-dose rosuvastatin JO - Int J Cardiol VL - 235 UR - https://doi.org/10.1016/j.ijcard.2017.02.099 DO - 10.1016/j.ijcard.2017.02.099 ID - Ran2017 ER - TY - JOUR AU - Sakamoto, K. AU - Kawamura, M. AU - Watanabe, T. PY - 2017 DA - 2017// TI - Effect of ezetimibe add-on therapy over 52 weeks extension analysis of prospective randomized trial (RESEARCH study) in type 2 diabetes subjects JO - Lipids Health Dis VL - 16 UR - https://doi.org/10.1186/s12944-017-0508-4 DO - 10.1186/s12944-017-0508-4 ID - Sakamoto2017 ER - TY - JOUR AU - Japaridze, L. AU - Sadunishvili, M. PY - 2017 DA - 2017// TI - The short-term effect of atorvastatin plus ezetimibe therapy versus atorvastatin monotherapy on clinical outcome in acute coronary syndrome patients by gender JO - Kardiol Pol VL - 75 UR - https://doi.org/10.5603/KP.a2017.0074 DO - 10.5603/KP.a2017.0074 ID - Japaridze2017 ER - TY - JOUR AU - Farnier, M. AU - Jones, P. AU - Severance, R. PY - 2016 DA - 2016// TI - Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: the ODYSSEY OPTIONS II randomized trial JO - Atherosclerosis. VL - 244 UR - https://doi.org/10.1016/j.atherosclerosis.2015.11.010 DO - 10.1016/j.atherosclerosis.2015.11.010 ID - Farnier2016 ER - TY - JOUR AU - Sakamoto, K. AU - Kawamura, M. AU - Kohro, T. PY - 2015 DA - 2015// TI - Effect of Ezetimibe on LDL-C lowering and Atherogenic lipoprotein profiles in type 2 diabetic patients poorly controlled by statins JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0138332 DO - 10.1371/journal.pone.0138332 ID - Sakamoto2015 ER - TY - JOUR AU - Saeedi, R. AU - Johns, K. AU - Frohlich, J. PY - 2015 DA - 2015// TI - Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients JO - Lipids Health Dis VL - 14 UR - https://doi.org/10.1186/s12944-015-0054-x DO - 10.1186/s12944-015-0054-x ID - Saeedi2015 ER - TY - JOUR AU - Le, N. A. AU - Tomassini, J. E. AU - Tershakovec, A. M. PY - 2015 DA - 2015// TI - Effect of switching from statin Monotherapy to Ezetimibe/simvastatin combination therapy compared with other intensified lipid-lowering strategies on lipoprotein subclasses in diabetic patients with symptomatic cardiovascular disease JO - J Am Heart Assoc VL - 4 UR - https://doi.org/10.1161/JAHA.114.001675 DO - 10.1161/JAHA.114.001675 ID - Le2015 ER - TY - JOUR AU - Matsue, Y. AU - Matsumura, A. AU - Suzuki, M. PY - 2013 DA - 2013// TI - Differences in action of atorvastatin and Ezetimibe in lowering low-density lipoprotein cholesterol and effect on endothelial function JO - Circ J VL - 77 UR - https://doi.org/10.1253/circj.CJ-13-0033 DO - 10.1253/circj.CJ-13-0033 ID - Matsue2013 ER - TY - JOUR AU - Okada, K. AU - Iwahashi, N. AU - Endo, T. PY - 2012 DA - 2012// TI - Long-term effects of ezetimibe-plus-statin therapy on low-density lipoprotein cholesterol levels as compared with double-dose statin therapy in patients with coronary artery disease JO - Atherosclerosis VL - 224 UR - https://doi.org/10.1016/j.atherosclerosis.2012.07.036 DO - 10.1016/j.atherosclerosis.2012.07.036 ID - Okada2012 ER - TY - JOUR AU - Averna, M. AU - Zaninelli, A. AU - Grazie, C. PY - 2010 DA - 2010// TI - Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patients JO - J Clin Lipidol VL - 4 UR - https://doi.org/10.1016/j.jacl.2010.05.002 DO - 10.1016/j.jacl.2010.05.002 ID - Averna2010 ER - TY - JOUR AU - Kater, A. -. L. A. AU - Batista, M. C. AU - Ferreira, S. R. PY - 2010 DA - 2010// TI - Synergistic effect of simvastatin and ezetimibe on lipid and pro-inflammatory profiles in pre-diabetic subjects JO - Diabetol Metab Syndr VL - 2 UR - https://doi.org/10.1186/1758-5996-2-34 DO - 10.1186/1758-5996-2-34 ID - Kater2010 ER - TY - JOUR AU - Phan, B. A. P. AU - Dayspring, T. D. AU - Toth, P. P. PY - 2012 DA - 2012// TI - Ezetimibe therapy: mechanism of action and clinical update JO - Vasc Health Risk Manag VL - 8 ID - Phan2012 ER - TY - JOUR AU - McKenney, J. M. AU - Jones, P. H. AU - Adamczyk, M. A. PY - 2003 DA - 2003// TI - Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin inachieving lipid goals: results from the STELLAR trial JO - Curr Med Res Opin VL - 19 UR - https://doi.org/10.1185/030079903125002405 DO - 10.1185/030079903125002405 ID - McKenney2003 ER - TY - JOUR AU - Higgins, J. P. AU - Thompson, S. G. AU - Deeks, J. J. AU - Altman, D. G. PY - 2003 DA - 2003// TI - Measuring inconsistency in meta-analyses JO - BMJ VL - 327 UR - https://doi.org/10.1136/bmj.327.7414.557 DO - 10.1136/bmj.327.7414.557 ID - Higgins2003 ER -